Mon.Nov 21, 2022

Why You Need an ADA Compliant Healthcare Website—and How to Get One

Healthcare Success

Just like your brick-and-mortar business has to be ADA compliant, your healthcare website must also be accessible to people with disabilities. The problem? The ADA doesn’t offer clear regulations for a compliant website. The bigger problem? ADA accessibility lawsuits are on the rise.

In cancers with very low survival rates, Sellas aims higher


The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer


What Matters Most: The Trends That Will Shape Pharma Marketing in 2023

Eversana Intouch

Download the White Paper. Big concepts. Big platforms. Big words. Big decisions. That’s where we all want to play. It’s easy to toss big words around, though: to be provocative, to hype, to make unsupported claims. It’s far more difficult to be precise, accurate, meaningful. To have impact.

Why the biopharma ‘IPO playbook’ changed in 2022


Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound

Exploring the “Other” End-User – HCPs and the Challenges to Adoption of Machine Learning-based Digital Solutions


Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST. us


Biotech Startup Raises $5.4M to Develop AI-Designed Protein Machines and Cell Factories


Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.


More Trending

Engagement Opportunities in Healthcare’s Digital Front Door


If you aren’t yet familiar with the term “digital front door,” you soon will be. Not only because we will soon define it for you, but because you will be hearing about it a lot over the next few years.

First-in-human gene therapy trial for major cardiac syndrome

European Pharmaceutical Review

The first-in-human gene therapy trial for heart failure patients with preserved ejection fraction (HFpEF) has been approved by the US Food & Drug Administration (FDA).

Provention prices type 1 diabetes drug Tzield at $194,000

Pharma Phorum

Provention Bio has priced its new type 1 diabetes (T1D) prevention therapy Tzield at $13,850 per vial – equivalent to almost $194,000 for its 14-day course – a higher level than had been predicted by industry observers.

ASH: AbbVie, J&J's Imbruvica under serious threat as BeiGene's Brukinsa delivers head-to-head trial win

Fierce Pharma

ASH: AbbVie, J&J's Imbruvica under serious threat as BeiGene's Brukinsa delivers head-to-head trial win. Mon, 11/21/2022 - 16:29

Merck’s $1.3B Imago Buyout Brings Blood Cancer Drug to Rival BMS, Incyte & GSK

MedCity News

Merck is acquiring Imago BioSciences, a clinical-stage biotech whose lead drug is in development for myelofibrosis and other blood cancers. The deal gives the pharmaceutical giant a small molecule that could provide an alternative to a class of drugs that introduce dangerous side effects.

Pfizer's Paxlovid access brought into question as WTO set to discuss patent waiver—again

Fierce Pharma

Pfizer's Paxlovid access brought into question as WTO set to discuss patent waiver—again. Mon, 11/21/2022 - 11:21

Therapeutic-first for cold agglutinin disease haemolytic anaemia

European Pharmaceutical Review

The European Commission (EC) has granted marketing authorisation for Enjaymo ® ( sutimlimab ), as the only approved treatment of haemolytic anaemia in adults with cold agglutinin disease (CAD).

Conservative group sues FDA in bid to overturn decades-old approval for abortion pill

Fierce Pharma

Conservative group sues FDA in bid to overturn decades-old approval for abortion pill. kdunleavy. Mon, 11/21/2022 - 10:01

Merck agrees to acquire Imago for $1.35bn

Pharmaceutical Technology

Merck (MSD outside North America) has signed a definitive agreement for the acquisition of all outstanding shares of Imago BioSciences, through a subsidiary, for $36.00 per each share in cash or for a total equity price of nearly $1.35bn.

SpaceX, ISS partner to test remote control of drug delivery technology on orbiting laboratory

Fierce Pharma

SpaceX, ISS partner to test remote control of drug delivery technology on orbiting laboratory. ntaylor. Mon, 11/21/2022 - 05:47

Why Value-based Care Needs To Be the Standard for Behavioral Health

MedCity News

Compared to other areas of healthcare, behavioral health has been slow to adopt VBC models — even though they will further expand access to behavioral health services, remove barriers to care, and improve the quality of mental health and substance use care.

GSK to slash about 150 consumer commercial jobs in India

Fierce Pharma

GSK to slash about 150 consumer commercial jobs in India. zbecker. Mon, 11/21/2022 - 10:56

It’s Time We Get Smart About Senior Care

MedCity News

These past two years have emphasized the importance of technology more than ever before.


The race for a new class of antibiotics

European Pharmaceutical Review

A study on the surge of new antimicrobial research has shown that despite almost a quarter of a million research papers (227,808) being published on the 12 bacterial families in the World Health Organization (WHO) global priority pathogen list of antibiotic-resistant bacteria from 2017, no new class of antibiotics has gone to market since 1987.

No Surprises Act Leads to Thousands More Disputes and Delays than Gov’t Expected

MedCity News

When the federal government enacted the No Surprises Act to lessen payment disputes between a patient or a health insurance plan and a provider, the government projected 22,000 disputes in 2022. However, between just April and September there were more than 90,000 disputes filed. .

Securing new drug development by establishing and maintaining phase-appropriate RSM designation from development to commercial launch


Webinar Date/Time: Mon, Dec 12, 2022 11:00 AM EST. us


CardieX Acquires Blumio, Incorporates Its Wearable Blood Pressure Sensor

MedCity News

CardieX, a cardiovascular technology company based in both Australia and Illinois, recently acquired Blumio, a San Mateo, California-based startup focused on cardiovascular sensors.


FDA Grants Breakthrough Therapy Status to Iveric Bio’s Zimura for AMD

Pharma Leaders

Iveric Bio plans on completing the new drug application by the end of this year. Compliance Channel Posts

UnitedHealthcare, AARP Team Up To Improve Access To Hearing Aids

MedCity News

Through the partnership, AARP members are able to purchase prescription and over-the-counter hearing aids through UnitedHealthcare Hearing. They’ll also be able to receive free hearing tests.

Hybrid Sales: Tips to Succeed in 2023


It’s no secret technology and the pandemic has transformed how businesses communicate with customers and prospects.

New Gene Therapy Biotech Telaria Launches With Rare Skin Disease Focus

MedCity News

Telaria is developing a gene therapy for the rare skin disorder recessive dystrophic epidermolysis bullosa. The company was formed by Replay, a gene therapy biotech that forms subsidiaries that leverage its platform technologies for writing and delivering genetic medicines.

Clinical Research News: Social Determinants Of Health Data Help Identify Sites For Trials

Clarify Health

Clinical Research News’ Deb Borfitz published an article about the importance of leveraging SDOH data to improve clinical trial diversity based on an interview with Clarify Health CEO and co-founder, Jean Drouin, MD. The original article was published here on November 15, 2022.

Find a Mentor, Be a Mentor


The business school at the University of Denver where I teach has a robust mentoring program. I mentor several students every year. But mentors are not just important for college students; they can be helpful to you no matter where you are in your career journey.


ProofPilot Announces Strategic Partnership with Savvy Cooperative


The partnership enables clinical trial sponsors to pressure test protocol designs with Savvy Cooperative patients through ProofPilot's digital protocol interface.

Precision Medicine Requires Opportunities to Connect with Patients


When Marc’s doctors discovered he had a rare liver condition, it almost felt like a relief. At least his enemy now had a name. But treatment didn’t seem to be working out as expected.

Episode 009: Navigating the Early Stage Start-Up with Sarah Kalil, Co-Founder and CEO of CoreMap

Med Device Careers

In this episode, we speak with Sarah Kalil, CEO and Co-founder of CoreMap. In our conversation, we discuss her experience raising capital, the “why” behind CoreMap’s mission, and instilling a winning culture early on in a company’s life.

Industry Briefs November 2022


CVS and Walgreens Announce Opioid Settlements. The two retail pharmacy giants have announced their intention to settle lawsuits regarding inappropriate opioid prescriptions at $5 billion each. Local and U.S.

The Science of Storytelling

Copyright Clearance Center

The post The Science of Storytelling appeared first on Copyright Clearance Center. CCC in the News